Genomic profiling of metastatic castration-resistant prostate cancer samples resistant to androgen receptor pathway inhibitors

N Menssouri, L Poiraudeau, C Helissey, L Bigot… - Clinical Cancer …, 2023 - AACR
Purpose: The androgen receptor axis inhibitors (ARPI; eg, enzalutamide, abiraterone
acetate) are administered in daily practice for men with metastatic castration-resistant …
被引用次数：6 相关文章

Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

N Menssouri, L Poiraudeau, C Helissey, L Bigot… - Clinical Cancer …, 2023 - AACR
Purpose: The androgen receptor axis inhibitors (ARPI; eg, enzalutamide, abiraterone
acetate) are administered in daily practice for men with metastatic castration-resistant …

Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

N Menssouri, L Poiraudeau… - … : an official journal …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose The androgen receptor axis inhibitors (ARPI; eg, enzalutamide, abiraterone
acetate) are administered in daily practice for men with metastatic castration-resistant …

Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

N Menssouri, L Poiraudeau, C Helissey… - Clinical Cancer …, 2023 - hal.science
Purpose: The androgen receptor axis inhibitors (ARPI; eg, enzalutamide, abiraterone
acetate) are administered in daily practice for men with metastatic castration-resistant …